Charles River Laboratories Intl. Inc vs Rockwell Automation — how do they compare? Charles River Laboratories Intl. Inc trades at $303.01 (market cap $14.23B), while Rockwell Automation trades at $433.14 (market cap $48.21B). The key difference: Rockwell Automation is far larger — about 3.4× Charles River Laboratories Intl. Inc's market cap, and Rockwell Automation pays a 1.27% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Rockwell Automation for 74 Days on average.
| CRL | ROK | |
|---|---|---|
Market Cap | $14.23B | $48.21B |
Volume | 1,176,885 | 953,342 |
Sector | Health | Industrials |
52-Week High | $310.77 | $495.08 |
52-Week Low | $149.93 | $333.75 |
Typical Hold Time | 33 Days | 74 Days |
Enterprise Value | $17.06B | $51.34B |
Dividend Yield | — | 1.27% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rockwell Automation (ROK) trades at $432.61, down 2.1% on the day, with a bearish technical signal. The stock shows strong profitability with a 13.38% net income margin and 34.47% ROE, but trades at elevated valuation multiples including a P/E of 40.65. Recent earnings have consistently beaten estimates, and the company maintains a solid cash flow profile. Positive news highlights its leadership in industrial automation and digital transformation initiatives.
The outlook is mixed: analyst consensus is a Buy with a $489.89 price target, implying potential upside, but high valuation and near-term technical weakness pose risks. Key catalysts include continued execution on automation demand trends, while risks involve macroeconomic sensitivity and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →